MUTHU RAJA, Karthick Raja and Roman HÁJEK. Regulatory Cells and Multiple Myeloma. In Ajay Gupta. Multiple Myeloma - An Overview. Rijeka: InTech, 2012, p. 33-60. Oncology. ISBN 978-953-307-768-0.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Regulatory Cells and Multiple Myeloma
Authors MUTHU RAJA, Karthick Raja (356 India, guarantor, belonging to the institution) and Roman HÁJEK (203 Czech Republic, belonging to the institution).
Edition Rijeka, Multiple Myeloma - An Overview, p. 33-60, 28 pp. Oncology, 2012.
Publisher InTech
Other information
Original language English
Type of outcome Chapter(s) of a specialized book
Field of Study 30200 3.2 Clinical medicine
Country of publisher Croatia
Confidentiality degree is not subject to a state or trade secret
Publication form printed version "print"
WWW URL
RIV identification code RIV/00216224:14110/12:00057252
Organization unit Faculty of Medicine
ISBN 978-953-307-768-0
Keywords in English Multiple Myeloma; Tumor Cells; Immune System; Regulatory Cells
Tags Immune regulatory subsets, multiple myeloma
Changed by Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 12/4/2013 17:49.
Abstract
Large evidence is available in hematological malignancies and solid tumors for elevated level of various regulatory and suppressor cells which impede anti-tumor responses. Therefore, targeting the regulatory cells could be a useful strategy to enhance the anti-tumor immunity. Approaches of depletion or inhibition of regulatory cells showed countable benefits in pre-clinical and clinical studies of some cancers including renal cell carcinoma, metastatic melanoma and colorectal carcinoma. Targeting regulatory T cells in a non-specific approach might cause detrimental autoimmune toxicities which is the key issue. Further studies are necessary to identify tumor associated regulatory cells which will enhance the depletion of specific regulatory cells but not the global population of regulatory cells.
Links
GAP304/10/1395, research and development projectName: Analýza klonálních progenitorů plazmatických buněk u monoklonálních gamapatií
Investor: Czech Science Foundation
LC06027, research and development projectName: Univerzitní výzkumné centrum - Česká myelomová skupina (Acronym: LC MGUS)
Investor: Ministry of Education, Youth and Sports of the CR, University Research Centre - Czech Myeloma Group
MSM0021622434, plan (intention)Name: Od klasických prognostických markerů ke klinicky aplikovatelným farmakogenomickým a farmakoproteomickým projektům u mnohočetného myelomu a monoklonálních gamapatií
Investor: Ministry of Education, Youth and Sports of the CR, From classic prognostic markers to clinical applications in selected pharmacogenomic and pharmacoproteomic projects in multiple myeloma and monoclonal gammapathies
NS10406, research and development projectName: Vytvoření prognostického panelu u pacientů s monoklonální gamapatií nejasného významu s cílem zabránění transformace v maligní onemocnění.
Investor: Ministry of Health of the CR
PrintDisplayed: 24/7/2024 12:28